AI assistant
Sending…
IRADIMED CORP — Director's Dealing 2023
May 10, 2023
32324_dirs_2023-05-10_5a0c2c59-087f-4ebd-9401-e8166b8c722d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2023-05-10
Reporting Person: ALLEN MONTY K (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-10 | Common Stock | S | 2786 | $46.0274 | Disposed | 17214 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $46.00 to $46.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from IRADIMED CORP
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 24
Interim / Quarterly Report
2026
May 1
Call Transcript
2026
May 1
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Feb 13
Call Transcript
2026
Feb 10
Earnings Release
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Director's Dealing
2026
Jan 27